0001213900-23-060425.txt : 20230728
0001213900-23-060425.hdr.sgml : 20230728
20230728075431
ACCESSION NUMBER: 0001213900-23-060425
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230721
FILED AS OF DATE: 20230728
DATE AS OF CHANGE: 20230728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daewoong Co., Ltd
CENTRAL INDEX KEY: 0001985493
STATE OF INCORPORATION: M5
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40021
FILM NUMBER: 231120238
BUSINESS ADDRESS:
STREET 1: 244, GALMACHI-RO, JUNGWON-GU
CITY: SEONGNAM-SI, GYEONGGI-DO
STATE: M5
ZIP: 13211
BUSINESS PHONE: 82-2-550-8800
MAIL ADDRESS:
STREET 1: 244, GALMACHI-RO, JUNGWON-GU
CITY: SEONGNAM-SI, GYEONGGI-DO
STATE: M5
ZIP: 13211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEON Biopharma, Inc.
CENTRAL INDEX KEY: 0001837607
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853940478
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PARK PLAZA
STREET 2: SUITE 1750
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: (949) 354-6499
MAIL ADDRESS:
STREET 1: 5 PARK PLAZA
STREET 2: SUITE 1750
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: Priveterra Acquisition Corp.
DATE OF NAME CHANGE: 20201222
3
1
ownership.xml
X0206
3
2023-07-21
0
0001837607
AEON Biopharma, Inc.
AEON
0001985493
Daewoong Co., Ltd
244, GALMACHI-RO, JUNGWON-GU
SEONGNAM-SI, GYEONGGI-DO
M5
13211
KOREA, REPUBLIC OF
0
0
1
0
Common Stock, $0.0001 par value per share
4177604
D
Common Stock, $0.0001 par value per share
2400000
I
Indirect Beneficial Ownership in the 2,400,000 owned by Daewoong Pharmaceutical Co., Ltd
Daewoong Co., Ltd., a company organized under the laws of the Republic of Korea, owns 51% of the outstanding shares of Daewoong Pharmaceutical Co., Ltd., a company organized under the laws of the Republic of Korea; Daewoong Co., Ltd. has voting power and dispositive power over Daewoong Pharmaceutical Co., Ltd. and therefore may be deemed to indirectly own such shares.
Daewoong Co., Ltd., By: /s/ Kyu Sung Lim, Authorized Signatory
2023-07-28